← Leaderboards
Don C Rockey
Medical University Of South Carolina
$16,593,570
Attributed
$16,593,570
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,235,561 · 16
VA$0 · 1
By mechanism
R01$14,079,040 · 6
P30$8,446,557 · 7
UE5$483,964 · 1
R25$216,000 · 1
R13$10,000 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Liver Diseases”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Larry Arthur$49,271,333
Research focus
Liver DiseasesProgramsAreaLiverMedicalPathogenesisInnovationPortal HypertensionResearch PersonnelFundingBiologyCellsBiomedical ResearchSouth CarolinaUniversitiesDigestive System DisordersRegulationPhenotypeFibrosisInjuryHepatic Stellate CellBaseMolecularInvestigation
Grant awards (69)
MUSC Digestive Disease Research Core Center$1,057,000
P30 · FY2025 · DK · contact PI
A Molecular Approach to the Pathogenesis of Portal Hypertension$413,771
R01 · FY2025 · DK · contact PI
Administrative Core$265,458
P30 · FY2025 · DK · contact PI
Medical University of South Carolina Mentoring Program in Digestive and Liver Diseases$161,182
UE5 · FY2025 · DK · contact PI
MUSC GI and Hepatology Medical Student Training Program$108,000
R25 · FY2025 · DK · contact PI
Enrichment Program$56,788
P30 · FY2025 · DK · contact PI
MUSC Digestive Disease Research Core Center$1,087,617
P30 · FY2024 · DK · contact PI
A Molecular Approach to the Pathogenesis of Portal Hypertension$470,590
R01 · FY2024 · DK · contact PI
Admin Core$238,392
P30 · FY2024 · DK · contact PI
Medical University of South Carolina Mentoring Program in Digestive and Liver Diseases$161,182
UE5 · FY2024 · DK · contact PI
MUSC GI and Hepatology Medical Student Training Program$108,000
R25 · FY2024 · DK · contact PI
Enrichment Program$58,072
P30 · FY2024 · DK · contact PI
Pathobiology of hepatic fibrosis and cirrhosis$0
I01 · FY2024 · VA · contact PI
MUSC Digestive Disease Research Core Center$1,087,617
P30 · FY2023 · DK · contact PI
Admin Core$238,392
P30 · FY2023 · DK · contact PI
Medical University of South Carolina Mentoring Program in Digestive and Liver Diseases$161,600
UE5 · FY2023 · DK · contact PI
Enrichment Program$58,072
P30 · FY2023 · DK · contact PI
Pathobiology of hepatic fibrosis and cirrhosis$0
I01 · FY2023 · VA · contact PI
MUSC Digestive Disease Research Core Center$1,087,617
P30 · FY2022 · DK · contact PI
Admin Core$238,392
P30 · FY2022 · DK · contact PI
MUSC Digestive Disease Research Core Center$122,986
P30 · FY2022 · DK · contact PI
Enrichment Program$58,072
P30 · FY2022 · DK · contact PI
Pathobiology of hepatic fibrosis and cirrhosis$0
I01 · FY2022 · VA · contact PI
MUSC Digestive Disease Research Core Center$1,087,617
P30 · FY2021 · DK · contact PI
Admin Core$238,392
P30 · FY2021 · DK · contact PI
Enrichment Program$58,072
P30 · FY2021 · DK · contact PI
Eastern DDRCC Alliance$23,920
P30 · FY2021 · DK · contact PI
MUSC Digestive Disease Research Core Center$1,087,617
P30 · FY2020 · DK · contact PI
A molecular approach to the pathogenesis of portal hypertension$336,943
R01 · FY2020 · DK · contact PI
Admin Core$238,392
P30 · FY2020 · DK · contact PI
Enrichment Program$58,072
P30 · FY2020 · DK · contact PI
A molecular approach to the pathogenesis of portal hypertension$339,050
R01 · FY2019 · DK · contact PI
A molecular approach to the pathogenesis of portal hypertension$341,488
R01 · FY2018 · DK · contact PI
A molecular approach to the pathogenesis of portal hypertension$341,373
R01 · FY2017 · DK · contact PI
The Cell and Molecular Biology of Myofibroblasts in Hepatic Fibrosis$325,163
R01 · FY2017 · DK · contact PI
The Cell and Molecular Biology of Myofibroblasts in Hepatic Fibrosis$325,163
R01 · FY2016 · DK · contact PI
The Cell and Molecular Biology of Myofibroblasts in Hepatic Fibrosis$325,163
R01 · FY2015 · DK · contact PI
The Cell and Molecular Biology of Myofibroblasts in Hepatic Fibrosis$325,163
R01 · FY2014 · DK · contact PI
Nitric Oxide and the Cellular Pathogenesis of Portal Hypertension$301,800
R01 · FY2012 · DK · contact PI
Nitric Oxide and the Cellular Pathogenesis of Portal Hypertension$13,442
R01 · FY2012 · DK · contact PI
Nitric Oxide and the Cellular Pathogenesis of Portal Hypertension$334,680
R01 · FY2011 · DK · contact PI
Nitric Oxide and the Cellular Pathogenesis of Portal Hypertension$373,032
R01 · FY2010 · DK · contact PI
Pathogenesis of Hepatic Fibrosis and Portal Hypertension$310,986
R01 · FY2010 · DK · contact PI
Nitric Oxide and the Cellular Pathogenesis of Portal Hypertension$376,800
R01 · FY2009 · DK · contact PI
Pathogenesis of Hepatic Fibrosis and Portal Hypertension$314,127
R01 · FY2009 · DK · contact PI
Regulation of Stellate Cell Contractility$342,836
R01 · FY2008 · DK · contact PI
Pathogenesis of Hepatic Fibrosis and Portal Hypertension$314,127
R01 · FY2008 · DK · contact PI
Pathogenesis of Hepatic Fibrosis and Portal Hypertension$320,537
R01 · FY2007 · DK · contact PI
Regulation of Stellate Cell Contractility$314,849
R01 · FY2007 · DK · contact PI
Pathogenesis of Hepatic Fibrosis and Portal Hypertension$330,111
R01 · FY2006 · DK · contact PI
Regulation of Stellate Cell Contractility$324,252
R01 · FY2006 · DK · contact PI
Regulation of Stellate Cell Contractility$253,836
R01 · FY2005 · DK
Regulation of Stellate Cell Contractility$77,472
R01 · FY2005 · DK
Regulation of Stellate Cell Contractility$349,210
R01 · FY2004 · DK
NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSION$187,603
R01 · FY2004 · DK
PATHOGENESIS OF HEPATIC FIBROSIS AND PORTAL HYPERTENSION$183,074
R01 · FY2004 · DK
PATHOGENESIS OF HEPATIC FIBROSIS AND PORTAL HYPERTENSION$113,927
R01 · FY2004 · DK
NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSION$55,982
R01 · FY2004 · DK
PATHOGENESIS OF HEPATIC FIBROSIS AND PORTAL HYPERTENSION$285,796
R01 · FY2003 · DK
NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSION$242,550
R01 · FY2003 · DK
Nitric Oxide and the Liver$10,000
R13 · FY2003 · DK
PATHOGENESIS OF HEPATIC FIBROSIS AND PORTAL HYPERTENSION$277,471
R01 · FY2002 · DK
NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSION$242,550
R01 · FY2002 · DK
PROSPECTIVE COMPARISON OF COLONIC IMAGING TEST$1,588,261
R01 · FY2001 · CA
PATHOGENESIS OF HEPATIC FIBROSIS AND PORTAL HYPERTENSION$269,388
R01 · FY2001 · DK
NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSION$266,635
R01 · FY2001 · DK
PROSPECTIVE COMPARISON OF COLONIC IMAGING TEST$1,642,310
R01 · FY2000 · CA
PATHOGENESIS OF HEPATIC FIBROSIS AND PORTAL HYPERTENSION$284,979
R01 · FY2000 · DK
NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSION$242,550
R01 · FY2000 · DK